Centers for Medicare and Medicaid Services (cms)

Finalized CMS rule on gender-affirming care may be harder to challenge legally than prior Trump-era efforts.

A Trump-era CMS policy shift delayed Medicare price negotiations for AbbVie’s blockbuster drug by seven years, per Public Citizen.